✓ checked
trust me, bro:
here is the receipt.
the claim
Children taking immunosuppressant drugs are more susceptible to infections than healthy children.
the verdict
SUPPORTED
the evidence backs this
Recorded sources
8 sources for · 0 against
Is it true that children taking immunosuppressant drugs are more susceptible to infections than healthy children?
Yes. Clinical evidence consistently demonstrates that children taking immunosuppressant drugs have heightened susceptibility to opportunistic and bacterial infections due to diminished immune surveillance.
Verdict: SUPPORTED · 8 sources for, 0 against · Last checked
The analysis
The claim is specific, empirical, and well-supported by multiple clinical studies involving pediatric populations on immunosuppressive regimens (e.g., transplant recipients, inflammatory bowel disease patients, and those on therapy for autoimmune diseases) who experience increased rates of infections.
Evidence for · 8
Discusses the management of immunosuppressive therapy and its associated risks in pediatric kidney transplant recipients.
Get citation
A, G., T, A., Z, A., N, B., AB, R., A, B., M, B., E, C., H, d. J., J, D., A, D., F, E., A, F., S, F., ML, G., B, G., C, G., J, H., B, H., S, J., N, K., JJ, K., U, K., R, L., M, L., S, M., A, M., G, N., L, O., J, O., N, P., A, P., C, P., M, P., E, P., A, P., S, R., M, S., R, S., T, S., J, S., S, T., B, T., DD, T., LT, W., M, N., & L, P. (2026). Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation.. doi.org. https://doi.org/10.1097/tp.0000000000005772
See more details
More for · 7
Identifies immunosuppressive therapy as a significant clinical factor associated with opportunistic infections and specific pathogen vulnerabilities in hospitalized children.
Get citation
Z, W., C, L., Y, Z., X, D., W, H., & Q, C. (2026). Clinical Characteristics and Antimicrobial Resistance Profiles of Pediatric Enterococcal Infections: A Comparison Between <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>.. doi.org. https://doi.org/10.3390/pathogens15090927
Notes that children receiving immunosuppressive treatment for conditions like Evans syndrome are at increased risk for severe visceral disseminated infections.
Get citation
RE, G., R, L., ME, N., JK, D., JC, C., & DT, C. (2026). Disseminated Varicella Zoster and Multiorgan Failure Requiring ECMO Support in a Patient With Evans Syndrome.. doi.org. https://doi.org/10.1155/crcc/2103304
Documents that pediatric liver transplant recipients on maintenance immunosuppression remain vulnerable to bacterial infections like Aeromonas bacteremia.
Get citation
T, M., M, Y., K, S., T, F., M, J., H, U., A, F., S, S., M, K., & C, O. (2026). Aeromonas Bacteremia in Pediatric Liver Transplant Recipients: Case-Based Experience of an Under-Recognized Infection.. doi.org. https://doi.org/10.1111/petr.70407
Links immunosuppressive therapy to reduced survival and increased vulnerability in children suffering from invasive fungal infections such as candidemia.
Get citation
C, E., U, C., E, K. T., K, C., M, Y. D., SE, K., G, G. O., G, O., N, K., E, A., G, T., M, K., A, C., DY, M., G, A., & Z, S. B. (2026). Clinical Characteristics, Management, and 30-Day Mortality Predictors in an 18-Year Pediatric Candidemia Cohort.. doi.org. https://doi.org/10.3390/jof12060445
Highlights that pediatric inflammatory bowel disease patients are more susceptible to gastrointestinal infections due in part to immunosuppressive therapy.
Get citation
RM, P., AC, H., S, B., & B, K. (2026). Bacterial Gastrointestinal Infections in Pediatric Inflammatory Bowel Disease (PIBD)-A Single-Center Experience of Epidemiology, Management, and Outcome.. doi.org. https://doi.org/10.3390/diagnostics16091411
Demonstrates how intensive immunosuppressive management for autoimmune conditions can unmask lethal opportunistic fungal infections in pediatric patients.
Get citation
LE, L. P., AM, P. V., MR, R. R., SE, R. M., & ST, M. M. (2026). Fulminant disseminated histoplasmosis in a pediatric patient with ataxia-telangiectasia and autoimmune hepatitis: A diagnostic and therapeutic challenge.. doi.org. https://doi.org/10.1016/j.idcr.2026.e02704
Reports that a significant proportion of pediatric kidney transplant recipients on immunosuppression develop clinically notable opportunistic infections.
Get citation
A, K., J, D., V, K., E, P., C, A., G, M., L, S., D, Z., G, T., G, G., G, P., & N, P. (2026). Timing and Clinical Impact of Opportunistic Infections in Pediatric Kidney Transplant Recipients: A 10-Year Single-Center Experience.. doi.org. https://doi.org/10.3390/jcm15124668
What does the evidence say?
The claim is specific, empirical, and well-supported by multiple clinical studies involving pediatric populations on immunosuppressive regimens (e.g., transplant recipients, inflammatory bowel disease patients, and those on therapy for autoimmune diseases) who experience increased rates of infections.
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work